DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-1.5%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.63B
AUM Growth
+$5.63B
(+18%)
Cap. Flow
+$590M
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
32.98%
Holding
167
New
29
Increased
30
Reduced
12
Closed
23
Top Buys
| 1 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$250M |
| 2 |
AdaptHealth
AHCO
|
$139M |
| 3 |
CMAX
CareMax, Inc. Class A Common Stock
CMAX
|
$129M |
| 4 |
Organogenesis Holdings
ORGO
|
$70.2M |
| 5 |
QuidelOrtho
QDEL
|
$52.4M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$110M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$88.6M |
| 3 |
Biogen
BIIB
|
$86.7M |
| 4 |
Centene
CNC
|
$72.2M |
| 5 |
The Oncology Institute
TOI
|
$54.3M |
Sector Composition
| 1 | Healthcare | 68.23% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cullinan Oncology
CGEM
$456M
| $26.9M | 0.48% |
+1,044,000
| New | +$26.9M |
|
52
Xeris Biopharma Holdings
XERS
$1.27B
| $26.7M | 0.47% |
6,553,398
| – | – |
|
53
Fate Therapeutics
FATE
$115M
| $26.4M | 0.47% |
304,000
| – | – |
|
54
Brookdale Senior Living
BKD
$1.81B
| $26.1M | 0.46% |
3,298,000
-4,192,845
| -56% | -$33.1M |
|
|
BPMC
55
DELISTED
Blueprint Medicines
BPMC
| $24.8M | 0.44% |
281,754
+72,754
| +35% | +$6.4M |
|
56
Aveanna Healthcare
AVAH
$1.74B
| $24.7M | 0.44% |
+2,000,000
| New | +$24.7M |
|
57
Cytokinetics
CYTK
$5.98B
| $24.5M | 0.44% |
1,238,083
-1,322,917
| -52% | -$26.2M |
|
58
NeueHealth
NEUE
$60.6M
| $24M | 0.43% |
+1,400,000
| New | +$24M |
|
|
KNTE
59
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $23.7M | 0.42% |
1,020,000
+675,000
| +196% | +$15.7M |
|
|
SPRB
60
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $22.9M | 0.41% |
+2,046,958
| New | +$22.9M |
|
61
Alector
ALEC
$282M
| $22M | 0.39% |
1,055,192
| – | – |
|
62
Instil Bio
TIL
$196M
| $21.6M | 0.38% |
1,115,739
| – | – |
|
|
MAACU
63
DELISTED
Montes Archimedes Acquisition Corp. Unit
MAACU
| $21.3M | 0.38% |
+2,000,000
| New | +$21.3M |
|
|
PROF
64
Profound Medical
PROF
$131M
| $21.2M | 0.38% |
1,297,797
| – | – |
|
65
Outset Medical
OM
$245M
| $20M | 0.36% |
+400,622
| New | +$20M |
|
66
Pharvaris
PHVS
$1.41B
| $19.2M | 0.34% |
1,032,757
| – | – |
|
67
Day One Biopharmaceuticals
DAWN
$766M
| $18.6M | 0.33% |
+818,980
| New | +$18.6M |
|
68
Stereotaxis
STXS
$246M
| $17.8M | 0.32% |
+1,843,000
| New | +$17.8M |
|
69
Janux Therapeutics
JANX
$1.38B
| $17.5M | 0.31% |
+700,000
| New | +$17.5M |
|
70
Quantum-Si Incorporated
QSI
$217M
| $17.2M | 0.3% |
+1,400,000
| New | +$17.2M |
|
71
Dyne Therapeutics
DYN
$1.92B
| $16.6M | 0.29% |
787,000
+101,000
| +15% | +$2.12M |
|
|
JBIO
72
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $16.3M | 0.29% |
+714,285
| New | +$16.3M |
|
|
BLUE
73
DELISTED
bluebird bio
BLUE
| $15.4M | 0.27% |
480,300
| – | – |
|
|
CMRX
74
DELISTED
Chimerix, Inc.
CMRX
| $14.5M | 0.26% |
1,816,221
| – | – |
|
75
Immunocore
IMCR
$1.78B
| $14.1M | 0.25% |
360,966
+189,058
| +110% | +$7.38M |
|